Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
about
Toxicology of nanomaterials used in nanomedicinePreparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursorsMultiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiencyIn vitro and in vivo models for the study of oral delivery of nanoparticlesMechanism of oral tolerance induction to therapeutic proteinsRecent advances in oral vaccine development: yeast-derived β-glucan particlesRecent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesSize selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipidsSynthetic Nanoparticles for Vaccines and ImmunotherapyThe gut wall provides an effective barrier against nanoparticle uptakeCoating with luminal gut-constituents alters adherence of nanoparticles to intestinal epithelial cellsPlant extract synthesized PLA nanoparticles for controlled and sustained release of quercetin: a green approachNanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 miceLectin-mediated bioadhesion: preparation, stability and caco-2 binding of wheat germ agglutinin-functionalized Poly(D,L-lactic-co-glycolic acid)-microspheres.Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa.Drug release from core-shell type nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran.Changes produced by external radiation in parameters influencing intestinal permeability and microparticle uptake in vitro.Surfactant-free formulation of poly(lactic/glycolic) acid nanoparticles encapsulating functional polypeptide: a technical note.Evaluation of mucoadhesive PLGA microparticles for nasal immunization.Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles.Oral absorption of hyaluronic acid and phospholipids complexes in rats.Development of nanoparticle-based magnetic resonance colonographyAssessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.Nanoparticles based on hydrophobic alginate derivative as nutraceutical delivery vehicle: vitamin D3 loading.Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions.Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation system.Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups.A promising gene delivery system developed from PEGylated MoS2 nanosheets for gene therapy.Treatment of Parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system.Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.Cell-Penetrating Penta-Peptides (CPP5s): Measurement of Cell Entry and Protein-Transduction ActivityOptical imaging of absorption and distribution of RITC-SiO2 nanoparticles after oral administration.Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheresPer-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in miceOrally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.Uptake of bright fluorophore core-silica shell nanoparticles by biological systemsEudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.Emerging technologies that overcome biological barriers for therapeutic protein delivery.
P2860
Q23914977-F756DF67-4D36-4635-9CEF-08A06DA7738DQ24648098-84545C95-529D-4484-8E80-18097D38D750Q26827999-AADCF399-8EBE-4EB1-B025-D7A29941BB7CQ26829514-2F71F753-BC81-43FE-888E-C3DEFEBC9838Q26866369-3DB7A139-F68A-44A3-BF5F-16CBDC0B9109Q27001699-181E922D-32DD-4B41-BEC5-8DB1EBA0CA9BQ27028129-04EE5927-C99A-4B36-9745-E1F07ABA9E33Q27334566-45D031B1-3566-4A51-86D1-D7E9EECD1097Q28085375-94D3622D-7FA8-4746-89C3-11DDCA954F5DQ28384695-34107708-7C3A-4848-A912-147B6903A9BDQ28384704-CF0BEEDC-BAB2-4A0B-B635-EBE50169B570Q28481474-8DD69C16-0464-4853-89B3-D2F5CBCF4C43Q30391507-6316AD8A-1905-4BB9-A5C1-F297EF623F21Q30540417-941B5180-410D-4185-AEC1-92B5B2574F1EQ30901159-3CC63CE5-D900-4938-A0F6-E83E564626FFQ33208470-BEDDCA9F-DD3C-4AD8-B596-53A8284C150CQ33232089-6DC39677-923C-45EC-AD18-043C49E5822AQ33333563-22FB727E-6E8A-4D76-B6C5-50524B770BEDQ33563560-971A4089-1A3E-43BB-800B-22D4BFED2575Q33749489-7A002FB6-6C92-4DA5-A146-61531B34ADF1Q33785598-0A655867-92FC-4BC4-BC32-5855D2905B4EQ33787782-FFE58AE1-DE2F-4ADF-94AE-23DAE9E34B55Q33825441-532DF56E-4646-41A2-9219-2F8B7DA9AA48Q33829582-0954D612-7071-469F-9D79-555A872D77B5Q33893117-8C227C8A-10AA-4837-91C9-2CBEE3B5EA3DQ33977471-15EC0A93-94C4-4332-8B3F-088B1115690FQ34021958-F01869AF-1357-482E-912C-C4FA66A1FA5CQ34088052-3F920915-C355-4117-9932-99B1877E09E3Q34124910-74FA1ED3-E8DE-496C-9444-8C9B135F0C1EQ34435548-036713DC-7732-4A9A-903F-881630C5E379Q34513956-F3B24100-C2DD-4435-83E3-1AA86D53E70EQ34568549-E61678F4-D2FF-4F29-B3A5-2C9C209F572BQ34606888-3446A34B-8246-4F09-A8A3-C78E463E83DEQ34787869-7E93C450-584E-43C1-94EB-41C00AE19203Q34901313-A9DCAE05-0773-461F-8C02-15977FEBC3B6Q35117688-72CAA5D1-D51F-4841-86C9-536384619702Q35124399-1E622287-D4BB-467F-9170-17A09F508704Q35136067-55425346-71B7-483B-BAFE-7EB34F136888Q35488181-187471E9-C4A3-4937-A461-52DA9513B536Q35547264-270A1A8C-64AA-4953-86A9-A568F83C8F18
P2860
Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
@en
type
label
Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
@en
prefLabel
Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
@en
P2093
P356
P1476
Gastrointestinal uptake of biodegradable microparticles: effect of particle size.
@en
P2093
G L Amidon
V Labhasetwar
P304
P356
10.1023/A:1016085108889
P577
1996-12-01T00:00:00Z